![]() |
Cincinnati Children’s Hosp Medical Ctr via AP |
A coronavirus vaccine from Pfizer proved 90% effective in early results, thrilling Wall Street and offering the world a dose of optimism at a critical point in the fight against the pandemic
The New York company said the remarkable findings were based on its examination of 94 infections within the vaccine and placebo arms of its study of 40,000 participants.
Pfizer and German partner BioNTech will continue to count cases and form a final analysis, though the interim results suggest Pfizer is on track to request emergency approval from federal regulators this month.
“Today is a great day for science and humanity. The first set of results from our phase 3 COVID-19 vaccine trial provides the initial evidence of our vaccine’s ability to prevent COVID-19,” said Pfizer Chairman and CEO Albert Bourla.
The news reverberated around the country and sent stocks soaring, as investors seized on the development as a sign of better days ahead. The U.S. is recording more than 100,000 new infections per day and passed 10 million cases on Monday, signaling a difficult winter unless things turn around. --->READ MORE HERE
![]() |
POOL/AFP via Getty Images |
Gus Perna was asked during an interview on CBS News’ “60 Minutes” on Sunday how quickly a vaccine would begin to be delivered to 300 million Americans.
“Within 24 hours,” Perna said.
The veteran Army supply officer put in charge of the distribution effort by President Trump said everything would start rolling once he issues an “execute” order. --->READ MORE HEREFollow links below to related stories and resources:
COVID immunity could last over a year after taking Pfizer’s vaccine
COVID-19 Paycheck Protection Program fraud accusations continue to mount
Nursing home resident says she ‘just wants to die’ over isolation from loved ones
USA TODAY: Coronavirus Updates
WSJ: Coronavirus Live Updates
YAHOO NEWS: Coronavirus Live Updates
NEW YORK POST: Coronavirus The Latest
If you like what you see, please "Like" us on Facebook either here or here. Please follow us on Twitter here.
No comments:
Post a Comment